Living with Sickle Cell Disease means that every treatment comes with its own side effects. Today, we will focus on the dangers of blood exchange or transfusion and the risk of iron overload.
Strategies to reduce disease burden in alpha- or beta-thalassemia, sickle cell disease, and polycythemia vera, and insights into anemia in IBD, are among anemia highlights from ASH 2024.
Alongside the FDA’s orphan drug designation in the U.S., the European Commission’s orphan medicinal product designation for mitapivat underscores the urgent need for novel therapies for sickle cell ...